Join our webinar on Thursday February 23rd, at 12.00pm CET!
How can it help to improve patient’s outcome?
Join our webinar featuring Prof. Daniele De Luca who will discuss the results of a controlled before-after quality improvement study, published in 2021 in the “Anesthesia, Analgesia and Critical Care” journal.
This study shows that NIV-NAVA, delivered as first-line noninvasive respiratory support (NRS) in pediatric moderate AHRF of infectious origin, is associated with a lower intubation rate, shorter PICU and hospital length of stay, as well as early improvement of physiological parameters compared to NIV-PS traditional treatment including endotracheal intubation and mechanical ventilation.
Join Prof. Daniele De Luca on Thursday February 23rd at 12.00pm CET.